4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-043032
EVP, Research & CSO acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-06-23 | Option exercise | +8,000 | $1.53 | $12,240 | 99,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2021-06-23 | Option exercise · Stock Option (Right to Buy) | −8,000 | 290,755 | D | ||
Loading xslF345X03/doc4.xml…